Most importantly, in correlation with our in vitro data, the ex vivo treatment of MPBCs with FasL prior to transplantation in conditioned NOD-SCID IL-2Rγnull (NSG) mice prevented GvHD and improved stem cell transplantation. Here, FASLG is linked to graft versus host disease.